EUVIMEDEUVIMED entdecken
Open Access

Rationale and design of a randomized controlled clinical trial of a resilience-building intervention in adults with congenital heart disease

Jill M Steiner, Arisa Rei Marshall, Adrienne H Kovacs, Ruth A Engelberg, Lyndia Brumback, Karen K Stout, Chris T Longenecker, Joyce P Yi-Frazier, Abby R Rosenberg

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Jill M Steiner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine & Cambia Palliative Care Center of Excellence, University of Washington, 1959 NE Pacific St., Seattle,…. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Quality of Life, Resilience, Psychological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adults with congenital heart disease (ACHD) are at risk for lower quality of life (QOL) and psychological health. Behavioral interventions to meet their psychosocial needs are lacking. The aim of this study is to evaluate the feasibility of implementing the Promoting Resilience in Stress Management (PRISM) intervention in ACHD and its efficacy in increasing resilience in this population. METHODS: We designed a phase II randomized controlled clinical trial of patients with moderate or complex ACHD, physiological stages C or D. Enrolled participants will be randomized to receive PRISM or usual care. PRISM is a manualized, skills-based behavioral intervention comprised of four one-on-one sessions targeting resilience resources (stress-management, goal-setting, cognitive reframing, meaning making), an optional session on advance care planning, and a facilitated family meeting. Participants in both groups will complete study questionnaires at enrollment and 3-months later. The primary aim is to describe feasibility, namely the proportions of patients who a) enroll in the study among those eligible, and b) complete the PRISM intervention among those randomized to that arm. We will also evaluate PRISM's efficacy by using linear regression models to compare changes in mean resilience scores between assigned groups. In exploratory analyses, we will evaluate effects on QOL, psychological distress, perceived competence for health care management, and comfort with advance care planning. DISCUSSION: This study will provide rigorous evidence to determine the feasibility and efficacy of a brief intervention to promote resilience and psychosocial health in ACHD. Findings may guide the development of a future multi-site effectiveness study. CLINICAL TRIAL REGISTRATION: NCT04738474.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalQuality of LifeResilience, PsychologicalAdultFemaleHumansMaleAdvance Care PlanningCognitive Behavioral TherapyFeasibility StudiesGoalsPsychosocial InterventionResearch DesignStress, PsychologicalRandomized Controlled Trials as TopicClinical Trials, Phase II as Topic

Stichwörter der Autor:innen

Behavioral interventionClinical trialCongenital heart diseaseQuality of lifeResilience

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine & Cambia Palliative Care Center of Excellence, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA. Electronic address: jills8@uw.edu.
  • Division of Cardiology, Department of Medicine, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA.
  • Equilibria Psychological Health, 10-255 The East Mall, Toronto, Ontario M9B 0A9, Canada.
  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine & Cambia Palliative Care Center of Excellence, University of Washington, Harborview Medical Center, 325 9th Ave, Seattle, WA 98104, USA.
  • Department of Biostatistics, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA.
  • Division of Cardiology and Department of Global Health, University of Washington, 3980 15th Ave NE, Seattle, WA 98105, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Steiner, J. M., Marshall, A. R., Kovacs, A. H., Engelberg, R. A., Brumback, L., Stout, K. K., Longenecker, C. T., Yi-Frazier, J. P., & Rosenberg, A. R. (2024). Rationale and design of a randomized controlled clinical trial of a resilience-building intervention in adults with congenital heart disease. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107638

Vancouver

Steiner JM, Marshall AR, Kovacs AH, Engelberg RA, Brumback L, Stout KK, et al. Rationale and design of a randomized controlled clinical trial of a resilience-building intervention in adults with congenital heart disease. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107638

BibTeX
@article{Steiner2024,
  author = {Steiner, Jill M and Marshall, Arisa Rei and Kovacs, Adrienne H and Engelberg, Ruth A and Brumback, Lyndia and Stout, Karen K and Longenecker, Chris T and Yi-Frazier, Joyce P and Rosenberg, Abby R},
  title = {Rationale and design of a randomized controlled clinical trial of a resilience-building intervention in adults with congenital heart disease},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107638}
}
Kostenlos starten →